SEC Form 4 · accession 0001190725-16-000404
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G Grey
Director
Period of report
May 18, 2016
Accepted (ET)
May 19, 2016 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option Grant (Right to Buy)F1 | $15.72 | May 18, 2016 | A | 10,000 | A | — | May 17, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.